Institutional members access full text with Ovid®

Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China

Cysique, Lucette Aa,g; Letendre, Scott Lb; Ake, Christophera; Jin, Huaa,d; Franklin, Donald Ra; Gupta, Saurabha; Shi, Chuane; Yu, Xine; Wu, Zunyouf; Abramson, Ian Sc; Grant, Igora; Heaton, Robert Ka; and the HIV Neurobehavioral Research Center group

doi: 10.1097/QAD.0b013e32833336c8
Clinical Science

Objective: To quantify and characterize the nature of cognitive change over 1 year in a cohort of HIV-positive former plasma donors in rural China.

Design: The present study is an observational cohort study.

Methods: One hundred and ninety-two HIV-positive and 101 demographically comparable HIV-negative individuals, all former plasma donors, who lived in a rural part of China, received comprehensive medical and neuropsychological examinations. At study entry, 56% of HIV-positive group was on combination antiretroviral treatment and 60.9% at follow-up. Multiple regression change score approach was used with the HIV-negative sample to develop norms for change that would be then applied to the HIV-positive participants. Follow-up test scores adjusted for the control group practice effect.

Results: Fifty-three HIV-positive individuals (27%) developed significant cognitive decline as compared with five (5%) HIV-negative individuals. Cognitive decline was predicted at baseline by AIDS status, lower nadir CD4, and worse processing speed; at follow-up, it was associated with lower current CD4 cell count and failure of viral suppression on combination antiretroviral treatment. Neuropsychological decline also was associated with decreased independence in activities of daily living. Using neuropsychological impairment scores that were corrected for ‘practice’ on repeated testing, we found that among the decliners, 41.5% (N = 22) had incident impairment, whereas 38% (N = 20) declined within the impaired range and another 20.7% (N = 11) declined within the normal range.

Conclusion: The present study demonstrates that despite ongoing combination antiretroviral treatment, cognitive decline in HIV-positive people is common over a 1-year follow-up. Regression-based norms for change on western neuropsychological tests can be used to detect disease-related cognitive decline in a developing country.

aDepartment of Psychiatry, USA

bDepartment of Medicine, USA

cDepartment of Mathematics, and HIV Neurobehavioral Research Center (HNRC), University of California at San Diego, USA

dVA San Diego Healthcare System, San Diego, California, USA

eInstitute of Mental Health, Peking University, China

fNational Center for AIDS/STD Control & Prevention (NCAIDS), Beijing, China

gDepartment of Psychiatry, Brain Sciences, University of New South Wales, Sydney, Australia.

Received 26 July, 2009

Revised 31 August, 2009

Accepted 18 September, 2009

Correspondence to Robert K. Heaton, Department of Psychiatry, University of California San Diego, 9500 Gilman Drive #0603, La Jolla, CA 92093-0603, USA. Tel: +1 858 534 4044; fax: +1 858 534 9917; e-mail: rheaton@ucsd.edu

© 2010 Lippincott Williams & Wilkins, Inc.